NPPA fixes retail prices of key combination drugs, exclusive of GST

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 38 essential combination drugs listed under Schedule-I of the Drugs (Prices Control) Order, 2013. These prices are fixed exclusive of GST, which means GST will be charged separately on these drugs. The move aims to regulate prices, ensure availability, and improve affordability of vital combination medicines essential for public health. Price control is expected to protect consumers from unreasonable price hikes while ensuring pharmaceutical companies maintain supply. NPPA’s order applies uniformly across India, reinforcing the government’s commitment to affordable healthcare and monitoring essential drug prices rigorously.